Literature DB >> 568910

Disk agar diffusion susceptibility testing of yeasts.

M A Saubolle, P D Hoeprich.   

Abstract

A disk agar diffusion method was developed for testing the susceptibility of rapidly growing yeasts in vitro. A totally defined, completely synthetic agar culture medium (synthetic amino acid medium, fungal) and clinical isolates of Candida spp. and Torulopsis glabrata were used. Turbidimetric adjustment of cell suspensions resulted in standard, reproducible inocula, which gave sharp, clear zones of inhibition when applied by an agar overlay method. Optimal disk loads were determined for amphotericin B, amphotericin B methyl ester, 5-fluorocytosine, clotrimazole, and miconazole. Disk potencies were stable over a 2-month period when stored in a vacuum desiccator at -30 degrees C. Using an error ratebounded classification, the zones of inhibition were correlated with both broth dilution and agar dilution minimum inhibitory concentrations (MICs). With amphotericin B and amphotericin B methyl ester, all isolates were susceptible, yielding zone diameters which clustered within 5 mm. Overall correlations between zone diameters and broth dilution MICs with 5-fluorocytosine, miconazole, and clotrimazole were 97, 96, and 82% (excluding T. glabrata), respectively; correlations of zone diameters with agar dilution MICs were 96, 92, and 88%, respectively. Disk diffusion susceptibility testing of yeasts appears to be generally applicable. However, when results are equivocal, quantitative test methods should be used.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 568910      PMCID: PMC352501          DOI: 10.1128/AAC.14.4.517

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  34 in total

1.  Editoral: Treatment of fungal infections.

Authors:  J A Krick; J S Remington
Journal:  Arch Intern Med       Date:  1975-02

2.  Comparative in vitro antifungal activity of amphotericin B and amphotericin B methyl ester.

Authors:  W R Howarth; R P Tewari; M Solotorovsky
Journal:  Antimicrob Agents Chemother       Date:  1975-01       Impact factor: 5.191

Review 3.  Chemotherapy of systemic fungal diseases.

Authors:  P D Hoeprich
Journal:  Annu Rev Pharmacol Toxicol       Date:  1978       Impact factor: 13.820

4.  Obfuscation of the activity of antifungal antimicrobics by culture media.

Authors:  P D Hoeprich; P D Finn
Journal:  J Infect Dis       Date:  1972-10       Impact factor: 5.226

5.  Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.

Authors:  C M Metzler; R M DeHaan
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

6.  Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole.

Authors:  P D Hoeprich; A C Huston
Journal:  J Infect Dis       Date:  1975-08       Impact factor: 5.226

7.  In vitro studies with miconazole and miconazole nitrate.

Authors:  S Shadomy; L Paxton; A Espinel-Ingroff; H J Shadomy
Journal:  J Antimicrob Chemother       Date:  1977-03       Impact factor: 5.790

8.  Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing.

Authors:  C J Utz; S Shadomy
Journal:  J Infect Dis       Date:  1977-06       Impact factor: 5.226

9.  Antimicrobial activity of econazole and miconazole in vitro and in experimental candidiasis and aspergillosis.

Authors:  G Schär; F H Kayser; M C Dupont
Journal:  Chemotherapy       Date:  1976       Impact factor: 2.544

10.  Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester.

Authors:  P D Hoeprich; A C Huston
Journal:  J Infect Dis       Date:  1976-10       Impact factor: 5.226

View more
  8 in total

1.  Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations.

Authors:  R Pelletier; J Peter; C Antin; C Gonzalez; L Wood; T J Walsh
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

Review 2.  Antifungal Susceptibility Testing: Current Approaches.

Authors:  Elizabeth L Berkow; Shawn R Lockhart; Luis Ostrosky-Zeichner
Journal:  Clin Microbiol Rev       Date:  2020-04-29       Impact factor: 26.132

Review 3.  Antifungal susceptibility testing.

Authors:  J H Rex; M A Pfaller; M G Rinaldi; A Polak; J N Galgiani
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

4.  Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States.

Authors:  R L Stiller; J E Bennett; H J Scholer; M Wall; A Polak; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

5.  Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome.

Authors:  M Radetsky; R C Wheeler; M H Roe; J K Todd
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

6.  In vitro susceptibility to 5-fluorocytosine and nystatin of common clinical yeast isolates.

Authors:  G Nobre; T Sobral; A F Ferreira
Journal:  Mycopathologia       Date:  1981-01-30       Impact factor: 2.574

7.  Analysis of pH and buffer effects on flucytosine activity in broth dilution susceptibility testing of Candida albicans in two synthetic media.

Authors:  D L Calhoun; J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

8.  A simple and inexpensive quantitative technique for determining chemical sensitivity in Saccharomyces cerevisiae.

Authors:  Chao-Wei Hung; Jorge Y Martínez-Márquez; Fatima T Javed; Mara C Duncan
Journal:  Sci Rep       Date:  2018-08-09       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.